Acarbose: Clinical Trials

8 trials of Acarbose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 18Completed 8

Follow Acarbose: new trials by email Literature Review of Acarbose trials Research Report on Acarbose

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CGM-Guided Acarbose for Painful Diabetic Neuropathy
Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications
Phase 1CompletedShifa International Hospital1702025-09-012026-03-03
Bioequivalence Study for Acarbose/Metformin FDC
Acarbose/Metformin FDC(BAY81-9783), Glucobay, Glucophage - Diabetes Mellitus, Type 2
Phase 1CompletedBayer242019-10-142020-04-13
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Exenatide, Acarbose, Exenatide Placebo - Hyperinsulinemic Hypoglycemia
Phase 1CompletedUniversity of Minnesota112016-02-012021-05-06
Bioequivalence Study for Acarbose / Metformin FDC
Acarbose/Metformin FDC (BAY81-9783), Acarbose (Glucobay, BAYG5421), Metformin - Diabetes Mellitus, Type II
Phase 1CompletedBayer402012-09-012012-12-19
A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg
Acarbose (Glucobay ODT, BAYG5421), Acarbose (Glucobay, BAYG5421) - Diabetes Mellitus, Type 2
Phase 1CompletedBayer342012-03-012013-06-14
A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet
Acarbose (Glucobay ODT, BAYG5421), Acarbose (Glucobay, BAYG5421) - Diabetes Mellitus, Type 2
Phase 1CompletedBayer332011-06-012013-08-28
Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers
BI 44847, Acarbose, Japanese diet - Healthy
Phase 1CompletedBoehringer Ingelheim372008-10-012014-08-08
Treatment of Orthostatic Hypotension in Autonomic Failure
Atomoxetine, Acarbose, Pyridostigmine Bromide - Autonomic Failure, Orthostatic Hypotension
Phase 1CompletedVanderbilt University3892002-03-012017-01-18

Conditions studied

Diabetes Mellitus, Type 2 (4)  ·  Congenital Hyperinsulinism (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Neuropathies (1)  ·  Hypotension, Orthostatic (1)  ·  Pain (1)  ·  Pure Autonomic Failure (1)

Sponsors

Bayer (4)  ·  Boehringer Ingelheim (1)  ·  Shifa International Hospital (1)  ·  University of Minnesota (1)  ·  Vanderbilt University (1)

Countries

Germany (2)  ·  United States (2)  ·  China (1)  ·  Pakistan (1)  ·  South Korea (1)

Top investigators

Italo Biaggioni, MD (1)  ·  Shalamar D Sibley, MD (1)

Results publications

PMID 10662747, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12832331, PMID 15066944, PMID 15710782, PMID 15738343, PMID 17515447, PMID 17515448, PMID 20837887, PMID 22311903, PMID 27271310, PMID 39727053, PMID 9727818